Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SHARx is a healthcare services company that provides a specialized advocacy platform to help employers and employees access high-cost specialty medications. The company focuses on navigating complex manufacturer assistance programs, grants, and other alternative funding sources to reduce the financial burden of life-saving treatments. By integrating with existing pharmacy benefit plans, SHARx identifies cost-saving opportunities for medications that are typically expensive or excluded from standard coverage. Their model aims to lower the total cost of care for self-insured employers while improving patient adherence and health outcomes. In 2021, SHARx was acquired by HealthJoy, a benefits navigation platform, to expand its suite of clinical and cost-containment solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SHARx.